| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |